Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -344,874 | -304,707 | -127,502 | -51,006 | -27,125 |
| Depreciation Amortization | 16,395 | 2,938 | 582 | 12 | N/A |
| Accounts payable and accrued liabilities | -54 | -1,641 | -978 | -52 | 70 |
| Other Working Capital | 19,586 | 53,150 | -12,126 | -1,033 | 43 |
| Other Operating Activity | 148,459 | 39,125 | 8,783 | 5,484 | 1,009 |
| Operating Cash Flow | $-160,488 | $-211,135 | $-131,241 | $-46,595 | $-26,003 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,422 | -1,693 | N/A | N/A | N/A |
| Purchase Of Investment | -879,067 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 567,500 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-316,989 | $-1,693 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 322,874 | 212,912 | N/A | 26,365 | 0 |
| Debt Repayment | N/A | -28,701 | N/A | N/A | N/A |
| Common Stock Issued | 392,416 | 112,710 | 131,921 | 151,262 | 0 |
| Other Financing Activity | -23,112 | 91,620 | -18 | 19,748 | 14,863 |
| Financing Cash Flow | $692,178 | $388,541 | $131,903 | $197,375 | $14,863 |
| Exchange Rate Effect | 359 | 4 | -38 | N/A | 0 |
| Beginning Cash Position | 351,985 | 176,268 | 175,644 | 24,864 | 36,004 |
| End Cash Position | 567,045 | 351,985 | 176,268 | 175,644 | 24,864 |
| Net Cash Flow | $215,060 | $175,717 | $624 | $150,780 | $-11,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -160,488 | -211,135 | -131,241 | -46,595 | -26,003 |
| Capital Expenditure | -5,422 | -1,693 | N/A | N/A | N/A |
| Free Cash Flow | -165,910 | -212,828 | -131,241 | -46,595 | -26,003 |